CoChat

High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma

Open access
Hoda, Mir Alireza, Rozsas, Anita, Lang, Elisabeth, Klikovits, Thomas, Lohinai, Zoltan, Torok, Szilvia, Berta, Judit, Bendek, Matyas, Berger, Walter, Hegedus, Balazs, Klepetko, Walter, Renyi-Vamos, Ferenc, Grusch, Michael, Dome, Balazs, Laszlo, Viktoria · 2016 · Oncotarget
Cited by 57

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

// Mir Alireza Hoda 1,2,* , Anita Rozsas 1,3,* , Elisabeth Lang 2 , Thomas Klikovits 1 , Zoltan Lohinai 3 , Szilvia Torok 3 , Judit Berta 3 , Matyas Bendek 3 , Walter Berger 2 , Balazs Hegedus 1,4 , Walter Klepetko 1 , Ferenc Renyi-Vamos 5 , Michael Grusch 2 , Balazs Dome 1,3,5,6,** and Viktoria Laszlo 1,** 1 Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria 2 Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria 3 National Koranyi Institute of Pulmonology, Budapest, Hungary 4 MTA-SE Molecular Oncology Research Group, Hungarian Academy of Sciences, Budapest, Hungary 5 Department of Thoracic Surgery, National Institute of Oncology and Semmelweis University, Budapest, Hungary 6 Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria * These authors share the first authorship ** These authors are co-senior authors of this study Correspondence to: Viktoria Laszlo, email: // Balazs Hegedus, email: // Keywords : activin A, lung adenocarcinoma, biomarker, metastasis, follistatin, Pathology Section Received : November 20, 2015 Accepted : February 09, 2016 Published : February 29, 2016 Abstract Activin A (ActA)/follistatin (FST) signaling has been shown to be deregulated in different tumor types including lung adenocarcinoma (LADC). Here, we report that serum ActA protein levels are significantly elevated in LADC patients (n=64) as compared to controls (n=46, p =0.015). ActA levels also correlated with more advanced disease stage ( p <0.0001) and T ( p =0.0035) and N (p=0.0002) factors. M1 patients had significantly higher ActA levels than M0 patients ( p <0.001). High serum ActA level was associated with poor overall survival ( p <0.0001) and was confirmed as an independent prognostic factor ( p =0.004). Serum FST levels were increased only in female LADC patients (vs. female controls, p=0.031). Two out of five LADC cell lines secreted biologically active ActA, while FST was produced in all of them. Transcripts of both type I and II ActA receptors were detected in all five LADC cell lines. In conclusion, our study does not only suggest that measuring blood ActA levels in LADC patients might improve the prediction of prognosis, but also indicates that this parameter might be a novel non-invasive biomarker for identifying LADC patients with organ metastases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.7796

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 57

Metadata

Authors
Hoda, M. A., Rozsas, A., Lang, E., Klikovits, T., Lohinai, Z., Torok, S., Berta, J., Bendek, M., Berger, W., Hegedus, B., Klepetko, W., Renyi-Vamos, F., Grusch, M., Dome, B., & Laszlo, V.
Venue
Oncotarget
Published
2016-02-29
Volume
7
Issue
12
Pages
13388-13399
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2290778503
Cited by
57
References
2
FWCI
3.31
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma. https://app.cochat.ai/papers/10.18632/oncotarget.7796
The paper
Hoda, M. A., Rozsas, A., Lang, E., Klikovits, T., Lohinai, Z., Torok, S., Berta, J., Bendek, M., Berger, W., Hegedus, B., Klepetko, W., Renyi-Vamos, F., Grusch, M., Dome, B., & Laszlo, V. (2016). High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma. Oncotarget. https://doi.org/10.18632/oncotarget.7796

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.